Cyclosporine 0.09% Solution (Cequa) for Dry Eye Disease

Date: July 29, 2019 Issue #:  1577Summary:  The FDA has approved cyclosporine 0.09% ophthalmic solution (Cequa– Sun) to increase tear production in patients with keratoconjunctivitis sicca (dry eye disease).Restasis, a 0.05% cyclosporine emulsion, was approved in the US in 2003 for the same indication.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: Tags: Cequa Cyclosporine Dry eye disease lifitegrast Restasis Verkazia Xiidra Source Type: research